Prospective study for predictive biomarkers and modified risk scoring model for venous thromboembolism in Japanese patients with unresectable or metastatic cancer.
Not Applicable
- Conditions
- lung cancer, esophageal cancer, gastric cancer, biliary tract cancer, pancreatic cancer, colorectal cancer
- Registration Number
- JPRN-UMIN000026826
- Lead Sponsor
- Clinical Research Center, Saga University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 240
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients have history of VTE in the past. 2. Patients have recently received radiotherapy except for palliative radiation therapy, chemotherapy and surgery except for minor surgery within the last 4 weeks. 3. Patients using anticoagulant drugs (warfarin, heparin and Direct oral anticoagulants) consistently. 4. Patients have serious renal disease: creatinine clearance<30ml/min, or hypersensitivity to CT contrast media. 5. Patients with active infections. 6. Pregnant or possibly pregnant women. 7. Patients with lower limb amputation. 8. Patients who are inappropriate as a subject of the study judged by the treating physicians or investigator.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Objectively confirmed symptomatic or asymptomatic VTE
- Secondary Outcome Measures
Name Time Method Khorana risk score, Vienna CATS risk score, final values of risk score, final values of biomarkers, amount of change in risk score, amount of change in biomarkers, rate of change in risk score, rate of change in biomarkers, all values of risk score, all values of biomarkers